Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 3808  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
  »  Article in PDF (445 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

  In this Article
 »  References

 Article Access Statistics
    PDF Downloaded79    
    Comments [Add]    
    Cited by others 5    

Recommend this journal


Table of Contents    
Year : 2018  |  Volume : 66  |  Issue : 7  |  Page : 141-142

ADCY5-related dyskinesia

Department of Pediatrics, KLE University's J N Medical College, Belgaum, Karnataka, India

Date of Web Publication1-Mar-2018

Correspondence Address:
Dr. Mahesh Kamate
Department of Pediatrics, KLE University's J N Medical College, Belgaum - 590 010, Karnataka
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0028-3886.226449

Rights and Permissions

How to cite this article:
Kamate M, Mittal N. ADCY5-related dyskinesia. Neurol India 2018;66, Suppl S1:141-2

How to cite this URL:
Kamate M, Mittal N. ADCY5-related dyskinesia. Neurol India [serial online] 2018 [cited 2023 Nov 29];66, Suppl S1:141-2. Available from:


Evaluating a child who is suffering from a developmental delay that is associated with abnormal limb movements, albeit with a normal neuroimaging, is difficult. Unfortunately, there are no characteristic clinical clues that may hint towards the existing diagnosis in most of these types of dyskinesias, except in a few types of dyskinesias that are associated with a diurnal variation with worsening in the evening. The latter may be a characteristic feature found in dihydroxyphenylalanine (DOPA)-responsive dystonias. Another genetic dyskinesia that may present with characteristic clinical clues is the adenylate cyclase (ADCY5) gene-related dyskinesias, which have a marked exacerbation during the period of drowsiness prior to sleeping, are associated with a prolonged latency during this period when the patient is trying to go off to sleep, and may especially occur during arousal from sleep.[1],[2],[3]

A 12-year old boy, born to parents related by third-degree consanguinity, with a normal birth history, presented with delayed attainment of motor milestones as well as clumsiness, and abnormal movements of limbs. The abnormal movements were of maximum amplitude and frequency in the morning as soon as he woke up, lasted for 30–60 minutes, and then subsided on their own. After this period, he could perform his routine activities. The movements increased after the patient was sitting in a constant place for a long time, such as while undertaking long journeys and after episodes of illnesses. He was very restless in bed during his sleep, and his sleep would be extremely disturbed on most days. There was no family history of a similar illness. The child did not respond to treatment with medications like levodopa–carbidopa combination, high-dose trihexyphenidyl (30 mg per day), clonazepam, tetrabenazine, haloperidol, valproate, or carbamazepine. He had bilateral choreoathetosis with facial myokymia [Video 1]. From the age of 3 years, the child had been extensively examined at different neurological centres. Magnetic resonance imaging of the brain; tandem mass spectrometry; urine gas chromatography/mass spectrometry; serum lactate, ammonia, copper, ceruloplasmin as well as uric acid; and, renal and liver function tests were normal. Worsening of symptoms that occurred in the morning, the characteristic restlessness during sleep, and the associated facial myokymia suggested the presence of ADCY5-related dyskinesia. Blood was sent for assessment of the dystonia panel by next-generation sequencing, which revealed a heterozygous missense variation in exon-2 of the ADCY5 gene (chr: 3: 123071311;G.G/A; depth: 55x) that resulted in the amino acid substitution of tryptophan to arginine at codon 18 (C1252C>C/T). He was put on clonazepam and physiotherapy, which resulted in symptomatic improvement.

ADCY5-related dyskinesia is an infantile or childhood-onset disorder with a wide range of mixed hyperkinetic abnormal movements that include dystonia, chorea, tremors, and myoclonus, often with facial involvement.[1],[2] Most patients also have associated axial hypotonia.[3] The triggering factors for worsening of the clinical symptomatology include prolonged periods of inactivity, fatigue, anxiety, concurrent illnesses, or other stressors. The episodes may wax and wane over weeks to months. The dyskinesias become continuous or constant with increasing age, but the involuntary movements could still be absent during the rest phase of the illness.[1],[2] There are characteristic episodes of exacerbation of dyskinesias, which may also serve to interrupt sleep. The patients characteristically have dyskinesias during the interim period of drowsiness prior to sleeping, that often prevents the initiation of sleep so that the patient may sometimes lie writhing for hours after retiring to bed; some studies have reported dyskinesias associated with awakening in the early morning after sleep.[4]

ADCY5 dyskinesia is caused by a gain of functional mutations in the ADCY-5 gene that integrates signals from multiple receptors, including the D1 and D2 striatal dopamine receptors. Clonazepam and clobazam have an indirect inhibitory effect on adenylyl cyclase-5 activity, potentially counteracting the gain of function that has been shown to occur due to the mutation.[2],[3]

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient has given his consent for his images and other clinical information to be reported in the journal. The patient understands that name and initial will not be published and due efforts will be made to conceal identity, but anonymity cannot be guaranteed.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

 » References Top

Chang FC, Westenberger A, Dale RC, Smith M, Pall HS, Perez-Dueñas B, et al. Phenotypic insights into ADCY5-associated disease. Mov Disord 2016;31:1033-40.  Back to cited text no. 1
Douglas AG, Andreoletti G, Talbot K, Hammans SR, Singh J, Whitney A, et al. ADCY5-related dyskinesia presenting as familial myoclonus-dystonia. Neurogenetics 2017;18:111-7.  Back to cited text no. 2
Chen DH, Méneret A, Friedman JR, Korvatska O, Gad A, Bonkowski ES, et al. ADCY5-related dyskinesia: Broader spectrum and genotype–phenotype correlations. Neurology 2015;85:2026-35.  Back to cited text no. 3
Mencacci NE, Erro R, Wiethoff S, Hersheson J, Ryten M, Balint B, et al. ADCY5 mutations are another cause of benign hereditary chorea. Neurology 2015;85:80-8.  Back to cited text no. 4

This article has been cited by
1 Scoping Review on ADCY5-Related Movement Disorders
Poornima Jayadev Menon, Christelle Nilles, Laura Silveira-Moriyama, Ruiyi Yuan, Claudio M. de Gusmao, Alexander Münchau, Miryam Carecchio, Steve Grossman, Gay Grossman, Aurélie Méneret, Emmanuel Roze, Tamara Pringsheim
Movement Disorders Clinical Practice. 2023;
[Pubmed] | [DOI]
2 ADCY5 Mutation-Movement Disorder with Sleep Disruption Improving with Caffeine
NeeluA Desai, DavidA Manchala, NehaI Patki
Neurology India. 2022; 70(5): 2211
[Pubmed] | [DOI]
3 An Update on the Phenotype, Genotype and Neurobiology of ADCY5-Related Disease
Arianna Ferrini, Dora Steel, Katy Barwick, Manju A. Kurian
Movement Disorders. 2021; 36(5): 1104
[Pubmed] | [DOI]
4 ADCY5-Related Dyskinesia in a Child with Sleep Related Paroxysmal Dyskinesia
Vikram V Holla, Koti Neeraja, Shweta Prasad, Nitish Kamble, Pramod Kumar Pal
The Indian Journal of Pediatrics. 2021; 88(3): 308
[Pubmed] | [DOI]
5 Is acupuncture effective in the treatment of COVID-19 related symptoms? Based on bioinformatics/network topology strategy
Zhenzhen Han, Yang Zhang, Pengqian Wang, Qilin Tang, Kai Zhang
Briefings in Bioinformatics. 2021; 22(5)
[Pubmed] | [DOI]


Print this article  Email this article
Online since 20th March '04
Published by Wolters Kluwer - Medknow